High dropout rate from aftercare program of antihepatitis C therapy for patients with history of injection drug use.

Akihiro TamoriSawako Uchida-KobayashiRitsuzo KozukaHiroyuki MotoyamaKanako YoshidaNaoshi OdagiriKohei KotaniEtsushi KawamuraHideki FujiiAtsushi HagiharaMasaru EnomotoNorifumi Kawada

Published in: JGH open : an open access journal of gastroenterology and hepatology (2020)

DAAs had a remarkable anti-HCV effect in patients with past-IDU who continued in an aftercare program. It is necessary to understand the characteristics of past-IDU patients to establish a support system for aftercare programs.

Keyphrases

end stage renal disease
quality improvement
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
public health
prognostic factors
patient reported outcomes
ultrasound guided
human immunodeficiency virus